Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 1
2004 3
2005 4
2006 4
2007 8
2008 14
2009 28
2010 29
2011 32
2012 41
2013 47
2014 49
2015 41
2016 43
2017 33
2018 32
2019 36
2020 31
2021 37
2022 36
2023 6
Text availability
Article attribute
Article type
Publication date

Search Results

492 results
Results by year
Filters applied: . Clear all
Page 1
Hormone Therapy and Other Treatments for Symptoms of Menopause.
Hill DA, Crider M, Hill SR. Hill DA, et al. Am Fam Physician. 2016 Dec 1;94(11):884-889. Am Fam Physician. 2016. PMID: 27929271 Free article. Review.
Women who cannot tolerate adverse effects of progestogens may benefit from a combined formulation of estrogen and the selective estrogen receptor modulator bazedoxifene. There is no highquality, consistent evidence that yoga, paced respiration, acupuncture, exercise, stres …
Women who cannot tolerate adverse effects of progestogens may benefit from a combined formulation of estrogen and the selective estrogen rec …
Drugs for postmenopausal osteoporosis.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2020 Jul 13;62(1602):105-112. Med Lett Drugs Ther. 2020. PMID: 32728009 Corrected and republished. Review. No abstract available.
Management of postmenopausal osteoporosis and the prevention of fractures.
Gambacciani M, Levancini M. Gambacciani M, et al. Panminerva Med. 2014 Jun;56(2):115-31. Epub 2014 Jun 19. Panminerva Med. 2014. PMID: 24942322 Free article.
HRT is able to preserve and even increase BMD at all skeletal sites, leading to a significant reduction in vertebral and non-vertebral fractures. Selective estrogen modulators (SERMs) as raloxifene and bazedoxifene reduce bone turnover and maintains or increases vertebral …
HRT is able to preserve and even increase BMD at all skeletal sites, leading to a significant reduction in vertebral and non-vertebral fract …
A compendium of kinetic modulatory profiles identifies ferroptosis regulators.
Conlon M, Poltorack CD, Forcina GC, Armenta DA, Mallais M, Perez MA, Wells A, Kahanu A, Magtanong L, Watts JL, Pratt DA, Dixon SJ. Conlon M, et al. Nat Chem Biol. 2021 Jun;17(6):665-674. doi: 10.1038/s41589-021-00751-4. Epub 2021 Mar 8. Nat Chem Biol. 2021. PMID: 33686292 Free PMC article.
From this dataset we identify dozens of ferroptosis suppressors, including numerous compounds that appear to act via cryptic off-target antioxidant or iron chelating activities. We show that the FDA-approved drug bazedoxifene acts as a potent radical trapping antioxidant i …
From this dataset we identify dozens of ferroptosis suppressors, including numerous compounds that appear to act via cryptic off-target anti …
Efficacy of Pharmacological Therapies for the Prevention of Fractures in Postmenopausal Women: A Network Meta-Analysis.
Barrionuevo P, Kapoor E, Asi N, Alahdab F, Mohammed K, Benkhadra K, Almasri J, Farah W, Sarigianni M, Muthusamy K, Al Nofal A, Haydour Q, Wang Z, Murad MH. Barrionuevo P, et al. J Clin Endocrinol Metab. 2019 May 1;104(5):1623-1630. doi: 10.1210/jc.2019-00192. J Clin Endocrinol Metab. 2019. PMID: 30907957
A significant reduction in vertebral fractures was observed with abaloparatide, teriparatide, parathyroid hormone 1-84, romosozumab, strontium ranelate, denosumab, zoledronate, risedronate, alendronate, ibandronate, raloxifene, bazedoxifene, lasofoxifene, estrogen with pro …
A significant reduction in vertebral fractures was observed with abaloparatide, teriparatide, parathyroid hormone 1-84, romosozumab, stronti …
Bazedoxifene: bazedoxifene acetate, TSE 424, TSE-424, WAY 140424.
[No authors listed] [No authors listed] Drugs R D. 2008;9(3):191-6. doi: 10.2165/00126839-200809030-00007. Drugs R D. 2008. PMID: 18457472
Bazedoxifene is a third-generation selective estrogen receptor modulator (SERM) that is being developed by Ligand Pharmaceuticals in collaboration with Wyeth. ...In addition, Wyeth conducted a phase II trial in Japan to investigate bazedoxifene dose-response in 375
Bazedoxifene is a third-generation selective estrogen receptor modulator (SERM) that is being developed by Ligand Pharmaceuticals in
Bazedoxifene.
Raina PM, Parmar M. Raina PM, et al. 2022 Oct 9. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. 2022 Oct 9. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 36256769 Free Books & Documents.
Bazedoxifene is a medication used in the treatment and management of osteoporosis. First approved by the FDA in 2013 as a combination drug, this drug primarily targets postmenopausal women, the population most susceptible to bone loss defects. Bazedoxifene belongs t
Bazedoxifene is a medication used in the treatment and management of osteoporosis. First approved by the FDA in 2013 as a combination
Bazedoxifene exhibits anti-inflammation and anti-atherosclerotic effects via inhibition of IL-6/IL-6R/STAT3 signaling.
Luo P, Wang Y, Zhao C, Guo J, Shi W, Ma H, Liu T, Yan D, Huo S, Wang M, Li C, Lin J, Li S, Lv J, Zhang C, Lin L. Luo P, et al. Eur J Pharmacol. 2021 Feb 15;893:173822. doi: 10.1016/j.ejphar.2020.173822. Epub 2020 Dec 23. Eur J Pharmacol. 2021. PMID: 33347820
The aim of this study is to evaluate the effect of Bazedoxifene in the progression of atherosclerosis in apolipoprotein E-deficient (ApoE-/-) mice. ...Bazedoxifene is an attractive novel therapeutic reagent for atherosclerosis diseases. ...
The aim of this study is to evaluate the effect of Bazedoxifene in the progression of atherosclerosis in apolipoprotein E-deficient ( …
A myeloid-stromal niche and gp130 rescue in NOD2-driven Crohn's disease.
Nayar S, Morrison JK, Giri M, Gettler K, Chuang LS, Walker LA, Ko HM, Kenigsberg E, Kugathasan S, Merad M, Chu J, Cho JH. Nayar S, et al. Nature. 2021 May;593(7858):275-281. doi: 10.1038/s41586-021-03484-5. Epub 2021 Mar 31. Nature. 2021. PMID: 33789339 Free PMC article.
We show that post-treatment induction of the STAT3 pathway is correlated with a lack of response to anti-TNF treatment in patients, and demonstrate in vivo in zebrafish the amelioration of the activated myeloid-stromal niche using the specific gp130 inhibitor bazedoxifene. …
We show that post-treatment induction of the STAT3 pathway is correlated with a lack of response to anti-TNF treatment in patients, and demo …
Bazedoxifene and bazedoxifene combined with conjugated estrogens for the management of postmenopausal osteoporosis.
Lewiecki EM. Lewiecki EM. Expert Opin Investig Drugs. 2007 Oct;16(10):1663-72. doi: 10.1517/13543784.16.10.1663. Expert Opin Investig Drugs. 2007. PMID: 17922629 Review.
Bazedoxifene acetate (WAY-140424; TSE-424) is an investigational non-steroidal indole-based selective estrogen receptor modulator (SERM) - also classified as an estrogen agonist/antagonist - that is being developed as a daily oral drug for the prevention and
Bazedoxifene acetate (WAY-140424; TSE-424) is an investigational non-steroidal indole-based selective estrogen receptor
492 results